Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Treasury Shares (2019 - 2025)

Neurogene (NGNE) has disclosed Treasury Shares for 4 consecutive years, with $252124.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares fell 47.21% year-over-year to $252124.0, compared with a TTM value of $252124.0 through Sep 2025, down 47.21%, and an annual FY2024 reading of $222530.0, changed N/A over the prior year.
  • Treasury Shares was $252124.0 for Q3 2025 at Neurogene, down from $271923.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $482384.0 in Q1 2024 and bottomed at $222530.0 in Q4 2024.